We are the 1st spin-off founded by researchers of Consorci Sanitari del Maresme (CSdM) in April 2022.
About AIMS
At AIMSMEDICAL™, we are a leading provider in the medical diagnostic field. Our ultimate goal is to transform how healthcare providers approach the screening and monitoring of conditions related to aging, such as oropharyngeal dysphagia, using our artificial intelligence-powered technology platform to enable quicker and more efficient patient assessment and care prioritization.
AIMSMEDICAL™ can provide your company with medical diagnostic services as well as assistance and consulting related to all your Software as a Service needs. Call us now to learn more.
Our story.
01
Our mission.
To develop AI-based software that helps healthcare professionals to improve the diagnosis and management of age-related illnesses.
02
Our vision.
To become a company leader in AI-driven solutions for healthcare centres worldwide, by improving patient outcomes and transforming the way healthcare professionals address age-related illnesses.
03
Trusted by Medical Professionals
“AIMS-OD has allowed us not only to screen patients efficiently and quickly but has also been the impetus for diagnosing and treating OD.”
Joan FornsDysphagia reference nurse at the Intermediate Care Unit of the Maresme i la Selva Health Corporation
“The fact that AIMS-OD indicates patients at risk of oropharyngeal dysphagia helps us detect clinical signs of alterations in swallowing efficacy and safety. Thus, we can personalize the adaptation of viscosities and the diet of patients according to their needs.”
Mireia ArdilaNurse (Monitor of the multipurpose intermediate care area) at the Mataró University Hospital.
“Using AIMS-OD in clinical practice has led to a 180% increase in clinical diagnoses of oropharyngeal dysphagia at the Mataró University Hospital.”
Nico MorónAssistant geriatrician at the Mataró University Hospital
AIMS Medical GRANTS
AIMS MEDICAL won the Creatic award for the best business initiative in the field of technology and innovation.
AIMS MEDICAL has received a prestigious Neotec grant to advance its AI-driven technology for diagnosing oropharyngeal dysphagia, aiming to enhance patient care and reduce healthcare costs.
AIMS MEDICAL has secured ACCIÓ funding to advance its AI screening platform for underdiagnosed geriatric diseases and expand its team.
AIMS MEDICAL Awarded the Torres Quevedo Grant to Advance AI-Based Research in Oropharyngeal Dysphagia.
AIMS MEDICAL receives the grant of the Generalitat de Catalunya for the incorporation of Catalan in technological products.
AIMS MEDICAL awarded ACCIÓ grant for Open and Disruptive Innovation Projects 2025.
Meet our Partners
With the support of
